Neurology

Arbor Scientia Group Recognized as a Top Veeva Solutions Provider for 2025 by Pharma Tech OutlookArbor Scientia Group Recognized as a Top Veeva Solutions Provider for 2025 by Pharma Tech Outlook

Arbor Scientia Group Recognized as a Top Veeva Solutions Provider for 2025 by Pharma Tech Outlook

Arbor Scientia Group continues paving the way in medical education, combining excellence in scientific storytelling and optimization of submission processes…

4 weeks ago
Investigational data presented at Heart Rhythm Society demonstrates promising multi-sensing capabilities of SANSA home sleep apnea testInvestigational data presented at Heart Rhythm Society demonstrates promising multi-sensing capabilities of SANSA home sleep apnea test

Investigational data presented at Heart Rhythm Society demonstrates promising multi-sensing capabilities of SANSA home sleep apnea test

SAN DIEGO, April 29, 2025 /PRNewswire/ -- Huxley Medical unveiled promising investigational data from the company's SANSA monitoring platform at…

4 weeks ago
Investigational data presented at Heart Rhythm Society demonstrates promising multi-sensing capabilities of SANSA home sleep apnea testInvestigational data presented at Heart Rhythm Society demonstrates promising multi-sensing capabilities of SANSA home sleep apnea test

Investigational data presented at Heart Rhythm Society demonstrates promising multi-sensing capabilities of SANSA home sleep apnea test

SAN DIEGO, April 29, 2025 /PRNewswire/ -- Huxley Medical unveiled promising investigational data from the company's SANSA monitoring platform at…

4 weeks ago
Investigational data presented at Heart Rhythm Society demonstrates promising multi-sensing capabilities of SANSA home sleep apnea testInvestigational data presented at Heart Rhythm Society demonstrates promising multi-sensing capabilities of SANSA home sleep apnea test

Investigational data presented at Heart Rhythm Society demonstrates promising multi-sensing capabilities of SANSA home sleep apnea test

SAN DIEGO, April 29, 2025 /PRNewswire/ -- Huxley Medical unveiled promising investigational data from the company's SANSA monitoring platform at…

4 weeks ago
Kriya Announces Thirteen Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2025Kriya Announces Thirteen Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2025

Kriya Announces Thirteen Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2025

– Kriya’s platform includes fully integrated best-in-class manufacturing and research capabilities to support parallel advancement of a broad pipeline of…

4 weeks ago
Kriya Announces Thirteen Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2025Kriya Announces Thirteen Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2025

Kriya Announces Thirteen Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2025

– Kriya’s platform includes fully integrated best-in-class manufacturing and research capabilities to support parallel advancement of a broad pipeline of…

4 weeks ago
Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle EastAnavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East

Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage…

1 month ago
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain InjuriesgammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries

ROCKAWAY, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced…

1 month ago
BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with First Patient EnrolledBioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with First Patient Enrolled

BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with First Patient Enrolled

SUNRISE-PD evaluating the Company’s anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson’s disease who have not been treated with carbidopa/levodopa…

1 month ago
AI, Neuromodulation & Thrombectomy Drive $7.6B Growth in U.S. Neurological Devices Market – New iData Research Report Forecasts $10B by 2030AI, Neuromodulation & Thrombectomy Drive $7.6B Growth in U.S. Neurological Devices Market – New iData Research Report Forecasts $10B by 2030

AI, Neuromodulation & Thrombectomy Drive $7.6B Growth in U.S. Neurological Devices Market – New iData Research Report Forecasts $10B by 2030

VANCOUVER, BC, April 15, 2025 /PRNewswire/ - A new U.S. Neurological Devices Market Report provides essential insights for CEOs, CFOs, product…

1 month ago